As of 2025-09-16, the Relative Valuation of Pharmala Biotech Holdings Inc (MDMA.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.11 CAD, the upside of Pharmala Biotech Holdings Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-09-12 | -6.74 |
| 2025-09-11 | -6.43 |
| 2025-09-10 | -6.43 |
| 2025-09-09 | -6.43 |
| 2025-09-08 | -6.74 |
| 2025-09-05 | -6.74 |
| 2025-09-04 | -7.97 |
| 2025-09-03 | -7.97 |
| 2025-09-02 | -7.97 |
| 2025-08-29 | -8.27 |
| 2025-08-28 | -7.66 |
| 2025-08-27 | -7.97 |
| 2025-08-26 | -7.97 |
| 2025-08-25 | -7.66 |
| 2025-08-22 | -7.97 |
| 2025-08-21 | -7.66 |
| 2025-08-20 | -7.66 |
| 2025-08-19 | -7.97 |
| 2025-08-18 | -7.97 |
| 2025-08-15 | -8.27 |
| 2025-08-14 | -7.66 |
| 2025-08-13 | -8.27 |
| 2025-08-12 | -8.58 |
| 2025-08-11 | -8.88 |
| 2025-08-08 | -8.27 |
| 2025-08-07 | -8.58 |
| 2025-08-06 | -9.50 |
| 2025-08-05 | -7.66 |
| 2025-08-01 | -6.13 |
| 2025-07-31 | -6.13 |
| 2025-07-30 | -6.43 |
| 2025-07-29 | -6.43 |
| 2025-07-28 | -6.13 |
| 2025-07-25 | -6.43 |
| 2025-07-24 | -6.43 |
| 2025-07-23 | -6.13 |
| 2025-07-22 | -6.13 |
| 2025-07-21 | -6.13 |
| 2025-07-18 | -6.13 |
| 2025-07-17 | -5.82 |
| 2025-07-16 | -6.13 |
| 2025-07-14 | -5.82 |
| 2025-07-11 | -6.13 |
| 2025-07-10 | -6.13 |
| 2025-07-09 | -6.13 |
| 2025-07-08 | -6.13 |
| 2025-07-07 | -6.13 |
| 2025-07-04 | -6.74 |
| 2025-07-03 | -6.74 |
| 2025-07-02 | -6.43 |